Magzter GOLDで無制限に
10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。
試す 金 - 無料
Why Hydrogen Water?
PRIME Magazine
|Oct - Nov 2017
The number of adults estimated to be living with diabetes has nearly quadrupled over 35 years, the World Health Organisation (WHO) has said, warning that it has increased drastically because of "the way people eat, move and live". Singapore has the second-highest proportion of diabetics among developed nations, a report in 2015, by the International Diabetes Federation (IDF) revealed.
-
Recent studies demonstrate that hydrogen-rich water health benefits include having a normalising effect on glucose in the body. In combination with powerful antioxidant properties, hydrogen-rich water improves insulin circulation and sensitivity, while also increasing levels of certain compounds that build insulin resistance. The end product is improved glucose metabolism, which can both prevent and slow the development of Type 2 Diabetes Mellitus and insulin resistance.
Hydrogen (H2) has recently been extensively studied for its therapeutic properties as a health regulator. It removes harmful free radicals to reduce cell damages accumulated, helps to fight against ageing and detoxifies, improving various health conditions and treats critical diseases including several cancers. These studies have analysed the benefits of hydrogen in the prevention and treatment of over 60 diseases including the following:
Diabetes
Cancers
Cardiovascular
Neurodegenerative diseases such as Alzheimer’s
Organ dysfunction
OTHER BENEFITS OF HYDROGEN WATER REDUCED FATIGUE
このストーリーは、PRIME Magazine の Oct - Nov 2017 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
PRIME Magazine からのその他のストーリー
PRIME Singapore
Living Large
The Illusion of Space in Small Homes
9 mins
February - March 2026
PRIME Singapore
Fend Off the Flames
Fire Safety Knowledge That Can Save Lives
7 mins
February - March 2026
PRIME Singapore
The World in Numbers
How Data Analytics Shapes Modern Decision-Making
14 mins
February - March 2026
PRIME Singapore
Thunder Struck
Chris Hemsworth: From God of Thunder to Hollywood Deity
29 mins
February - March 2026
PRIME Singapore
Ingesting Inflammation
Why Everyone is Talking About Anti-Inflammatory Diets
12 mins
February - March 2026
PRIME Singapore
Inked Later
Why More People Are Getting Tattoos After 40
7 mins
February - March 2026
PRIME Singapore
STUDY CONFIRMS ONE MONTH OF NO ALCOHOL MAKES REAL DIFFERENCE TO HEALTH
In 2013, Alcohol Change UK started the “Dry January” campaign, where people could commit to abstaining from drinking alcohol for the entire month.
2 mins
February - March 2026
PRIME Singapore
CERTAIN CHANGES IN DRIVING PATTERNS MAY POINT TO COGNITIVE DECLINE, DEMENTIA
Individuals with cognitive impairment are at a two-to five-fold increased risk of being involved in motor accidents, highlighting the deterioration of driving skills with a decline in cognitive function. A recent study published in Neurology suggests that changes in daily driving patterns recorded using a vehicle datalogger could reliably distinguish individuals with mild cognitive impairment (MCI) from those with normal cognition. The study’s findings suggest that data collected by vehicle data loggers could potentially be used in the early identification of individuals at risk of a motor crash or those with cognitive impairment, prior to in-person cognitive assessments or brain imaging scans. Driving data patterns could also serve as a tool to assess the effectiveness of interventions for treating cognitive impairment.
2 mins
February - March 2026
PRIME Singapore
LIFT ME UP
Volformer: The Rejuvenation Protocol Combining Precision Ultrasound and Volumetric RF
4 mins
February - March 2026
PRIME Singapore
TARGETING IDO1 FOR CANCER: NOVEL DEGRADERS SHOW PROMISE IN PRECLINICAL STUDIES
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these escape mechanisms. However, such therapies are not always successful. A research team from the Max Planck Institute for Molecular Physiology in Dortmund and the AITHYRA Institute in Vienna has now developed a new class of compounds that specifically target and destroy the enzyme IDO1 – a key molecular switch that tumours use to suppress immune responses. They were also able to show that iDegs (IDO1 degraders) inhibit tumour growth in mice with SKOV-3 tumours, thereby prolonging survival time. This approach could markedly enhance the efficacy of existing immunotherapies and open new avenues in the fight against cancer. The new research was published in the journal Nature.
3 mins
February - March 2026
Translate
Change font size